CYDY · Forms 3, 4, 5
Insider trades at CytoDyn Inc.
No open-market insider buys or sells at CytoDyn Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for CytoDyn Inc. (CYDY) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for CytoDyn Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Tanya Durkee Urbach | Director | Options or other derivatives | Form 4 | ||||
| Stephen M Simes | Director | Options or other derivatives | Form 4 | ||||
| Lishomwa C Ndhlovu | Director | Options or other derivatives | Form 4 | ||||
| Jacob P Lalezari | Chief Executive Officer | Options or other derivatives | Form 4 | ||||
| Robert E. Hoffman | Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| Ryan Dunlap | Director | Options or other derivatives | Form 4 | ||||
| Karen J Brunke | Director | Options or other derivatives | Form 4 | ||||
| Tyler Blok | Chief Legal Officer | Options or other derivatives | Form 4 | ||||
| Robert E. Hoffman | Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| Robert E. Hoffman | Chief Financial Officer | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.